Lorbriqua 25mg Tablet

Lorlatinib (25mg)

Genuine

Authenticity Assured

Prescription

required

Lorbriqua 25mg Tablet is used to treat adults with unresectable (unremovable), advanced, or recurrent forms of non-small cell lung cancer (NSCLC). It works by inhibiting an enzyme called anaplastic lymphoma kinase (ALK) and is given to patients who have an alteration in this enzyme.

Written By Dr. Surabhi Srivastava, BDS,
Reviewed By Dr. Varun Gupta, MD Pharmacology, MBBS,
Last updated on 11 Nov 2024 | 01:04 AM (IST)

₹102000

30 tablets

Gurgaon

Payment

Online only

Free Return

within 7 days

Expiry after

Sep, 2026

General Information

Contains

Lorlatinib (25mg)

Marketer

Pfizer Ltd

Storage

Store below 30°C

The content is shown in English

Product introduction

Furthermore, Lorbriqua 25mg Tablet is prescribed only to those patients who no longer respond to other ALK inhibitors, such as alectinib or ceritinib. Additionally, it is also effective in treating ALK-positive NSCLC that has spread to the brain.

Take this medicine with or without food, but preferably at the same time each day. Depending on the condition and response to the treatment, the doctor may alter the dose or stop the treatment for a short time. Continue taking this medicine for as long as the doctor has prescribed, and do not stop suddenly.

Some common side effects of Lorbriqua 25mg Tablet include edema (swelling in arms, legs, hands, and feet), peripheral neuropathy (numbness and tingling feeling in joints, arms, and legs), and cognitive disorders (confusion, forgetfulness, and lack of concentration or attention). It may also cause breathlessness, fatigue, weight gain, joint pain, mood changes, and diarrhea. Consult the doctor if any of these side effects are worrisome or worsen. They may adjust the medicine dose and suggest ways to manage them.

Let the doctor know if you have any medical conditions, such as kidney or heart disease, depression, seizures, problems with the heartbeat, or breathing problems. Also, let them know if you have high blood pressure, high levels of cholesterol, or diabetes before starting the treatment with this medicine. Pregnant or breastfeeding women should also consult their doctor before taking this medicine. Some other medications may affect the working of this tablet; therefore, tell the doctor about all the other medicines you may be taking before starting the treatment with this medicine.

There is a Patient Support Program/Patient Assistance Program available in India for this medicine, being managed by Tata 1mg. Please contact your prescribing doctor to know more about the same. You may also call on (1800-102-1618) for more details.

Uses of Lorbriqua Tablet

Treatment of Non-small cell lung cancer

Benefits of Lorbriqua Tablet

Treatment of Non-small cell lung cancer
Lorbriqua 25mg Tablet helps shrink the tumor size and restricts the spread of cancer to other parts of the body. This medicine can effectively treat cancer that has spread to the brain because it can cross the blood-brain barrier. This barrier is a network of blood and tissue that prevents infectious bacteria and other harmful substances from entering the brain. The use of Lorbriqua 25mg Tablet helps prevent disease progression and reduce the chances of recurrence over a long period.

Side effects of Lorbriqua Tablet

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of Lorbriqua

Peripheral neuropathy (tingling and numbness of feet and hand)
Breathlessness
Mood changes
Weight gain
Fatigue
Edema (swelling)
High blood pressure
Diarrhea
Cough
Joint pain
Hypercholesterolemia (high cholesterol)
Increased triglyceride level in blood

How to use Lorbriqua Tablet

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Lorbriqua 25mg Tablet may be taken with or without food, but it is better to take it at a fixed time.

How Lorbriqua Tablet works

Lorbriqua 25mg Tablet is an anti-cancer medication. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps to stop or slow the spread of cancer cells.

Safety advice

Alcohol

CONSULT YOUR DOCTOR

It is not known whether it is safe to consume alcohol with Lorbriqua 25mg Tablet. Please consult your doctor.

Pregnancy

CONSULT YOUR DOCTOR

Lorbriqua 25mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

Breast feeding

CAUTION

Lorbriqua 25mg Tablet should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.

Driving

CONSULT YOUR DOCTOR

It is not known whether Lorbriqua 25mg Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.

Kidney

CAUTION

Lorbriqua 25mg Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Lorbriqua 25mg Tablet may be needed. Please consult your doctor.
However, no dose adjustment is recommended for patients with mild or moderate renal impairment.

Liver

SAFE IF PRESCRIBED

Lorbriqua 25mg Tablet is safe to use in patients with liver disease. No dose adjustment of Lorbriqua 25mg Tablet is recommended.
However, recommended dosage regimen has not been established in cases of moderate to severe hepatic impairment.

Fact Box

Chemical Class

Phenylpropanoid derivatives

Habit Forming

Therapeutic Class

ANTI NEOPLASTICS

Action Class

Tyrosine kinase inhibitors

Want to know more

We provide you with authentic, trustworthy and relevant information

Have issue with the content

Disclaimer

Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.

Marketer details

Name: Pfizer Ltd
Address: The Capital, 1802, 18th Floor , Plot No. C-70, ‘G’ Block , Bandra Kurla Complex, Bandra East , Mumbai – 400051.

Vendor Details

Country of origin: Germany
A licensed vendor partner from your nearest location will deliver Lorbriqua 25mg Tablet. Once the pharmacy accepts your order, the details of the pharmacy will be shared with you. Acceptance of your order is based on the validity of your doctor's ℞ and the availability of this medicine.

In case of any issues, contact us

Email ID: [email protected]
Phone Number: 0124-4166666
Address: 5th Floor Tower - B of the Presidency Building, 46/4 Mehrauli Gurgaon Road, Sector 14, Gurugram, Haryana-122001, India

Lab tests offered by us

Why we need a prescription?

Lorbriqua 25mg Tablet

Payment

Free Return

Expiry after

General Information

Contains

Marketer

Storage

Product introduction

Uses of Lorbriqua Tablet

Benefits of Lorbriqua Tablet

Side effects of Lorbriqua Tablet

How to use Lorbriqua Tablet

How Lorbriqua Tablet works

Safety advice

Alcohol

Pregnancy

Breast feeding

Driving

Kidney

Liver

Fact Box

Chemical Class

Habit Forming

Therapeutic Class

Action Class

Want to know more

Have issue with the content

Disclaimer

Marketer details

Vendor Details

In case of any issues, contact us

Lab tests offered by us

Related/Popular tests